Supplier · Peer benchmark
Peer comparison
How Neuraxpharm stacks up against suppliers competing for the same workloads — based on overlap with its 2 signature CPV codes over the last 24 months. Target HQ: Wales.
Value band:
/
CohortNeuraxpharm(You)Dr Reddy's Laboratories (UK) LtdZENTIVA PHARMA UK LIMITEDBaxter Healthcare LtdSun Pharma UKMedequip Assistive Technology Ltd
iAuto-picked from 2 signature CPV codes · last 24 months overlap
Metric | DR Dr Reddy's Laboratories (UK) Ltd Peer · rank #1 | ZP ZENTIVA PHARMA UK LIMITED Peer · rank #2 | BH Baxter Healthcare Ltd Peer · rank #3 | SP Sun Pharma UK Peer · rank #4 | MA Medequip Assistive Technology Ltd Peer · rank #5 | NE Neuraxpharm (You) · target supplier |
|---|---|---|---|---|---|---|
01ActivityVolume, scale, freshness | ||||||
| 12-month contractedAward value, last 12m | £56.3m | £47.0m | £10.7m | £9.4m | £8.5m | — |
| Framework headroomPer-supplier share of framework ceilings | — | — | £309k | — | — | — |
| Total awarded (lifetime)All time, all contracts | £207.7m | £241.5m | £214.4m | £71.0m | £822.4m | £10.2m(−95%) |
| Contracts won (12m)Distinct awards last year | 10 | 12 | 14 | 6 | 6 | 2 |
How to read a target cell
The target column carries a delta — value compared to the peer median for that row. Direction-of-good varies by metric, so deltas are neutral.
Peer cell£499m(peer median £255m)
→
Target cell£11.7m(−97% vs median)
Money:
£N.Nm, £Nk, £N.NbnPercent: 42% · pp delta: (+12pp)Day delta: (−149 days) · missing: —